NTRA
Natera, Inc.
+15.50 (+4.49%)360.84USD536K成交股數52.0B市值–本益比(近四季)19.2股價營收比+37.7%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 753M+38% | 697M+39% | 666M+51% | 592M+43% | 547M+49% | 502M+61% | 440M+64% | 413M+58% | 368M | 311M | 268M | 261M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 228M | 211M | 175M | 173M | 146M | 129M | 96.9M | 89.1M | 88.6M | 83.0M | 77.2M | 78.2M |
| 銷售管理費用 | 327M | 328M | 291M | 309M | 311M | 267M | 214M | 198M | 194M | 161M | 155M | 153M |
| 營業利益 | −75.8M-31% | −93.5M+18% | −22.8M-42% | −97.6M+122% | −110M+49% | −79.2M-6% | −39.3M-65% | −43.9M-61% | −74.3M | −84.5M | −111M | −112M |
| 營業利益率 | -10.1% | -13.4% | -3.4% | -16.5% | -20.2% | -15.8% | -8.9% | -10.6% | -20.2% | -27.2% | -41.4% | -43.0% |
| 稅後淨利 | −67.0M-34% | −85.1M+27% | 47.3M-250% | −87.5M+134% | −101M+49% | −66.9M-14% | −31.6M-71% | −37.5M-66% | −67.6M | −78.0M | −109M | −111M |
| 淨利率 | -8.9% | -12.2% | 7.1% | -14.8% | -18.5% | -13.3% | -7.2% | -9.1% | -18.4% | -25.1% | -40.6% | -42.4% |
| 稀釋 EPS | -0.47-36% | -0.60+20% | 0.36-238% | -0.64+113% | -0.74+32% | -0.50-21% | -0.26-73% | -0.30-69% | -0.56 | -0.63 | -0.95 | -0.97 |
| 稀釋股數 | 143M | 142M | 137M | 137M | 136M | 135M | 124M | 123M | 121M | 115M | 115M | 114M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 1.1B | 1.1B | 1.1B | 1.0B | 1.0B | 974M | 893M | 797M | 814M | 642M | 669M | 381M |
| 應收帳款 | 422M | 418M | 297M | 286M | 309M | 318M | 307M | 336M | 289M | 278M | 255M | 260M |
| 存貨 | 80.3M | 70.7M | 68.4M | 64.6M | 54.3M | 50.4M | 48.7M | 41.0M | 43.0M | 40.8M | 42.1M | 42.7M |
| 總資產 | 2.7B | 2.6B | 2.4B | 1.8B | 1.8B | 1.7B | 1.6B | 1.5B | 1.5B | 1.4B | 1.4B | 1.2B |
| 有息負債 | – | – | – | – | – | – | – | – | – | 283M | – | – |
| 總負債 | 836M | 840M | 686M | 569M | 511M | 493M | 712M | 680M | 674M | 676M | 662M | 652M |
| 股東權益 | 1.8B | 1.8B | 1.7B | 1.3B | 1.2B | 1.2B | 879M | 837M | 794M | 765M | 785M | 596M |
| 負債比 | 31.5% | 32.1% | 28.6% | 31.3% | 29.1% | 28.4% | 44.8% | 44.9% | 45.9% | 46.9% | 45.8% | 52.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | 359M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 40.2M-10% | – | – | – | 44.5M | – | – | 27.0M | – | – | – |
| 資本支出 | – | 22.1M | – | – | – | 21.8M | – | – | 20.3M | – | – | – |
| 自由現金流 | – | 18.0M-20% | – | – | – | 22.6M | – | – | 6.7M | – | – | – |
| 折舊攤銷 | – | 14.5M | – | – | – | 9.2M | – | – | 7.1M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 2.6% | – | – | – | 4.5% | – | – | 1.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.3B
| Single Reportable | 2.3B | 100.0% | +35.9% |
|---|
地區2025 年度 · 2.3B
| 美國 | 2.3B | 98.2% | +36.6% |
|---|---|---|---|
| Europe Middle East India And Africa | 24.5M | 1.1% | +2.5% |
| Americas Excluding Us | 9.4M | 0.4% | +41.3% |
| Other Geographic Areas | 8.0M | 0.3% | -7.5% |
主要客戶2025 年度 · 2.3B
| Insurance Carriers | 2.2B | 94.1% | +38.1% |
|---|---|---|---|
| Laboratory Partners | 103M | 4.5% | +6.1% |
| Patients | 31.8M | 1.4% | +14.1% |
產品／服務2025 年度 · 2.3B
| 產品 | 2.3B | 99.6% | +36.2% |
|---|---|---|---|
| Licensing And Other | 10.3M | 0.4% | -13.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.3B | +35.9% | −208M | -9.0% | -1.52 | 109M |
| FY2024 | 1.7B | +56.7% | −190M | -11.2% | -1.53 | 69.2M |
| FY2023 | 1.1B | +32.0% | −435M | -40.2% | -3.78 | −286M |
| FY2022 | 820M | +31.1% | −548M | -66.8% | -5.57 | −479M |
| FY2021 | 625M | +60.0% | −472M | -75.4% | -5.21 | −376M |
| FY2020 | 391M | +29.3% | −230M | -58.8% | -2.84 | −202M |
| FY2019 | 302M | +17.3% | −125M | -41.3% | -1.79 | −68.4M |
| FY2018 | 258M | – | −128M | -49.7% | -2.22 | −74.5M |